Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds.

Item

http://www.wikidata.org/entity/Q36740930

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Structure-activity models of o ...... romising anticancer compounds.

@ast

Structure-activity models of o ...... romising anticancer compounds.

@en

type

Item

label

Structure-activity models of o ...... romising anticancer compounds.

@ast

Structure-activity models of o ...... romising anticancer compounds.

@en

prefLabel

Structure-activity models of o ...... romising anticancer compounds.

@ast

Structure-activity models of o ...... romising anticancer compounds.

@en

P1476

Structure-activity models of o ...... promising anticancer compounds

@en

P2093

Robert A Newman

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.

Tumor classification by partial least squares using microarray gene expression data.

Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures.

Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: oral clearance.

General linearized biexponential model for QSAR data showing bilinear-type distribution.

PLS dimension reduction for classification with microarray data.

Megavariate analysis of environmental QSAR data. Part I--a basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD).

A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scores

Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease.

P2888

1471-2210-8-12

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2210-8-12

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John C Boik

P577

2008-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5301181

http://www.w3.org/2001/XMLSchema#string

P6179

1033694950

http://www.w3.org/2001/XMLSchema#string

P698

18554402

http://www.w3.org/2001/XMLSchema#string

P932

2442056

http://www.w3.org/2001/XMLSchema#string